Completed PHASE4 INTERVENTIONAL 2-arm NCT00994006

The Absorption of Magnesium Oxide Compared to Citrate in Healthy Subjects

The Absorption of Supplemental Magnesium Oxide Compared to Magnesium Citrate in Healthy Subjects With no Apparent Heart Disease

Sponsor: Sheba Medical Center

Conditions Healthy Subjects Hypomagnesemia

Interventions Magnesium citrate Magnesium oxide

Updated 5 times since 2017 Last updated: May 3, 2011 Started: Jan 31, 2010 Primary completion: Mar 31, 2011 Completion: Mar 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Healthy Subjects and Hypomagnesemia, this trial is completed. The trial is conducted by Sheba Medical Center and has accumulated 5 data snapshots since 2010. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Jan 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Sheba Medical Center

Data source: Sheba Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Tel Hashomer, Ramat Gan, Israel